|
|
|
ONLINE FEATURES
Book Reviews
BW Video
Columnists
Interactive Gallery
Newsletters
Past Covers
Philanthropy
Podcasts
Special Reports
BLOGS
Auto Beat
Bangalore Tigers
Blogspotting
Brand New Day
Byte of the Apple
Economics Unbound
Eye on Asia
Fine On Media
Green Biz
Hot Property
Investing Insights
Management IQ
NEXT: Innovation
NussbaumOnDesign
Tech Beat
Working Parents
TECHNOLOGY
J.D. Power Ratings
Product Reviews
Tech Stats
Wildstrom: Tech Maven
AUTOS
Home Page
Auto Reviews
Classic Cars
Car Care & Safety
Hybrids
INNOVATION
& DESIGN Home Page Architecture Brand Equity Auto Design Game Room SMALLBIZ Smart Answers Success Stories Today's Tip INVESTING Investing: Europe Annual Reports BW 50 S&P Picks & Pans Stock Screeners Free S&P Stock Report SCOREBOARDS Hot Growth 100 Mutual Funds Info Tech 100 S&P 500 B-SCHOOLS Undergrad Programs MBA Blogs MBA Profiles MBA Rankings Who's Hiring Grads |  |
DECEMBER 12, 2005
Why Spectranetics Is Special  Tiny medical device maker Spectranetics (SPNC) has been a stock on the go, climbing since May from 5 to 11. Its devices are used to treat coronary artery ailments. Its CVX-300(R) laser is the only Food & Drug Administration-approved system for removing plaque and clots in blood vessels. In April, Spectranetics won FDA approval to use the laser for removing blockages in leg arteries. The company's laser is gaining "significant attention in the medical community," says Suraj Kalia of investment firm Rodman & Renshaw, who tags the stock "outperform," with a target of 14. Occlusions in arm and leg arteries will be a large market for Spectranetics, says Matt Duncan of investment firm Stephens. He expects earnings to jump from 3 cents a share on sales of $55 million in 2006 to 14 cents in 2007 on $68 million. Elizabeth Jones of Kornitzer Capital Management, which owns stock, says the volume of laser procedures are on the rise and puts Spectranetics in a "sweet spot" in a fast-growing market.
Note: Unless otherwise noted, neither the sources cited in Inside Wall Street nor their firms hold positions in the stocks under discussion. Similarly, they have no investment banking or other financial relationships with them.  By Gene G. Marcial
BW MALL
SPONSORED LINKS
Get BusinessWeek directly on your desktop with our RSS feeds.
Buy a link now! Add BusinessWeek news to your Web site with our headline feed. Click to buy an e-print or reprint of a BusinessWeek or BusinessWeek Online story or video. To subscribe online to BusinessWeek magazine, please click here. Learn more, go to the BusinessWeekOnline home page  | | |
 Copyright 2005, by The McGraw-Hill Companies Inc. All rights reserved.Terms of Use | Privacy Notice |
Printer-Friendly Version